相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control
Stephanie Schipmann et al.
JOURNAL OF NEUROSURGERY (2021)
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Michael Weller et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial
Maximilien Vermandel et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Reliability of intraoperative ultrasound in detecting tumor residual after brain diffuse glioma surgery: a systematic review and meta-analysis
Gianluca Trevisi et al.
NEUROSURGICAL REVIEW (2020)
Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis
Jane-Chloe Trone et al.
RADIATION ONCOLOGY (2020)
The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update
Paige Lundy et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
Ulrich Herrlinger et al.
LANCET (2019)
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A. Schalper et al.
NATURE MEDICINE (2019)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients
Denis Migliorini et al.
NEURO-ONCOLOGY (2019)
Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis
Farasat Kazmi et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data
Chong Hyun Suh et al.
NEURO-ONCOLOGY (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Brain white matter fibre tracts: a review of functional neuro-oncological relevance
Natalie L. Voets et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
OS07.3 Nivolumab in Combination With Radiotherapy With or Without Temozolomide in Patients With Newly Diagnosed Glioblastoma: Updated Results From CheckMate 143
A. Omuro et al.
NEURO-ONCOLOGY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
Manfred Westphal et al.
LANCET ONCOLOGY (2013)
Use of diffusion tensor imaging in glioma resection
Kalil G. Abdullah et al.
NEUROSURGICAL FOCUS (2013)
Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery
Walter Stummer et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review
Pieter L. Kubben et al.
LANCET ONCOLOGY (2011)
Corticosteroid Use in Patients with Glioblastoma at First or Second Relapse Treated with Bevacizumab in the BRAIN Study
James J. Vredenburgh et al.
ONCOLOGIST (2010)
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
et al.
NEUROSURGERY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Survival from brain tumours in England and Wales up to 2001
B. Rachet et al.
BRITISH JOURNAL OF CANCER (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Presurgical functional MR imaging of language and motor functions: Validation with intraoperative electrocortical mapping
Alberto Bizzi et al.
RADIOLOGY (2008)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Plasticity of language networks in patients with brain tumors: A positron emission tomography activation study
A Thiel et al.
ANNALS OF NEUROLOGY (2001)
分享论文
